A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis

NCT06080789 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Pancreatitis

Interventions

DRUG: RABI-767

Sponsor

Panafina, Inc.